• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿素合成先天性代谢缺陷患儿的神经学转归。尿素循环酶病的转归。

Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

作者信息

Msall M, Batshaw M L, Suss R, Brusilow S W, Mellits E D

出版信息

N Engl J Med. 1984 Jun 7;310(23):1500-5. doi: 10.1056/NEJM198406073102304.

DOI:10.1056/NEJM198406073102304
PMID:6717540
Abstract

We studied 26 children with inborn errors of urea synthesis who survived neonatal hyperammonemic coma. There was a 92 per cent one-year survival rate associated with nitrogen-restriction therapy and stimulation of alternative pathways of waste nitrogen excretion. Seventy-nine per cent of the children had one or more developmental disabilities at 12 to 74 months of age; the mean IQ was 43 +/- 6. There was a significant negative linear correlation between duration of Stage III or IV neonatal hyperammonemic coma and IQ at 12 months (r = -0.72, P less than 0.001) but not between the peak ammonium level (351 to 1800 microM) and IQ. There was also a significant correlation between CT abnormalities and duration of hyperammonemic coma (r = 0.85, P less than 0.01) and between CT abnormalities and concurrent IQ (r = -0.75, P less than 0.02). These results suggest that prolonged neonatal hyperammonemic coma is associated with brain damage and impairment of intellectual function. This outcome may be prevented by early diagnosis and therapy.

摘要

我们研究了26名尿素合成先天性缺陷且在新生儿高氨血症昏迷中存活下来的儿童。氮限制疗法以及刺激废氮排泄的替代途径使一年生存率达到了92%。79%的儿童在12至74个月大时出现了一种或多种发育障碍;平均智商为43±6。新生儿III期或IV期高氨血症昏迷的持续时间与12个月时的智商之间存在显著的负线性相关性(r = -0.72,P < 0.001),但最高血氨水平(351至1800微摩尔)与智商之间不存在相关性。CT异常与高氨血症昏迷持续时间之间也存在显著相关性(r = 0.85,P < 0.01),且CT异常与同时期智商之间也存在显著相关性(r = -0.75,P < 0.02)。这些结果表明,延长的新生儿高氨血症昏迷与脑损伤和智力功能损害有关。这种结果可通过早期诊断和治疗来预防。

相似文献

1
Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.尿素合成先天性代谢缺陷患儿的神经学转归。尿素循环酶病的转归。
N Engl J Med. 1984 Jun 7;310(23):1500-5. doi: 10.1056/NEJM198406073102304.
2
Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.尿素合成先天性缺陷的治疗:激活废氮合成与排泄的替代途径。
N Engl J Med. 1982 Jun 10;306(23):1387-92. doi: 10.1056/NEJM198206103062303.
3
Plasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma.尿素循环酶病中的血浆α-酮戊二酸及其作为高氨血症昏迷先兆的作用。
Pediatr Res. 1980 Dec;14(12):1316-9. doi: 10.1203/00006450-198012000-00008.
4
Urea cycle enzymopathies.尿素循环酶病
Semin Liver Dis. 1982 Nov;2(4):329-39. doi: 10.1055/s-2008-1040719.
5
Prospective treatment of urea cycle disorders.尿素循环障碍的前瞻性治疗。
J Pediatr. 1991 Dec;119(6):923-8. doi: 10.1016/s0022-3476(05)83044-6.
6
Congenital hyperammonemic syndromes.先天性高氨血症综合征
Clin Perinatol. 1976 Mar;3(1):3-14.
7
Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis.精氨酸,对于尿素合成先天性代谢缺陷患者而言是一种必需氨基酸。
J Clin Invest. 1984 Dec;74(6):2144-8. doi: 10.1172/JCI111640.
8
Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.尿素合成先天性代谢缺陷患儿发作性高氨血症的治疗
N Engl J Med. 1984 Jun 21;310(25):1630-4. doi: 10.1056/NEJM198406213102503.
9
Urea biosynthesis II. Normal and abnormal regulation.
Am J Clin Nutr. 1978 Jan;31(1):126-33. doi: 10.1093/ajcn/31.1.126.
10
[Urea cycle disorders].[尿素循环障碍]
Ryoikibetsu Shokogun Shirizu. 1995(8):367-9.

引用本文的文献

1
Biochemical Characterization of Disease-Associated Variants of Human Ornithine Transcarbamylase.人类鸟氨酸转氨甲酰酶疾病相关变体的生化特性
ACS Chem Biol. 2025 May 16;20(5):1059-1067. doi: 10.1021/acschembio.5c00043. Epub 2025 Mar 10.
2
Emergency Management of Intoxication-Type Inherited Metabolic Disorders.中毒型遗传性代谢疾病的应急处理
J Inherit Metab Dis. 2025 Mar;48(2):e70007. doi: 10.1002/jimd.70007.
3
Extracorporeal pediatric renal replacement therapy: diversifying application beyond kidney failure.体外小儿肾脏替代疗法:超越肾衰竭的多样化应用。
Pediatr Nephrol. 2025 Apr;40(4):923-932. doi: 10.1007/s00467-024-06533-z. Epub 2024 Oct 8.
4
Quo vadis ureagenesis disorders? A journey from 90 years ago into the future.尿素生成障碍疾病将去往何方?从 90 年前追溯到未来。
J Inherit Metab Dis. 2024 Nov;47(6):1120-1128. doi: 10.1002/jimd.12763. Epub 2024 Jun 4.
5
Argininosuccinate lyase deficiency causes blood-brain barrier disruption via nitric oxide-mediated dysregulation of claudin expression.精氨酸琥珀酸裂解酶缺乏通过一氧化氮介导的紧密连接蛋白表达失调导致血脑屏障破坏。
JCI Insight. 2023 Sep 8;8(17):e168475. doi: 10.1172/jci.insight.168475.
6
Relationship between longitudinal changes in neuropsychological outcome and disease biomarkers in urea cycle disorders.尿素循环障碍患者神经心理学结局的纵向变化与疾病生物标志物的关系。
Pediatr Res. 2023 Dec;94(6):2005-2015. doi: 10.1038/s41390-023-02722-y. Epub 2023 Jul 15.
7
Case report: Is exchange transfusion a possible treatment for metabolic decompensation in neonates with methylmalonic aciduria in the setting of limited resources?病例报告:在资源有限的情况下,换血疗法是否可能成为甲基丙二酸血症新生儿代谢失代偿的一种治疗方法?
Front Pediatr. 2022 Jul 25;10:926793. doi: 10.3389/fped.2022.926793. eCollection 2022.
8
Multisite Retrospective Review of Outcomes in Renal Replacement Therapy for Neonates with Inborn Errors of Metabolism.多中心回顾性研究代谢性先天性疾病新生儿肾脏替代治疗的结局。
J Pediatr. 2022 Jul;246:116-122.e1. doi: 10.1016/j.jpeds.2022.03.043. Epub 2022 Mar 28.
9
Continuous Renal Replacement Therapy for Two Neonates With Hyperammonemia.两名高氨血症新生儿的持续肾脏替代治疗
Front Pediatr. 2021 Nov 5;9:732354. doi: 10.3389/fped.2021.732354. eCollection 2021.
10
Hyperammonemia in Inherited Metabolic Diseases.遗传性代谢病中的高血氨症。
Cell Mol Neurobiol. 2022 Nov;42(8):2593-2610. doi: 10.1007/s10571-021-01156-6. Epub 2021 Oct 19.